flowstock

$LCTX will discuss progress with its COR1 preclinical program for corneal endothelial disease during a conference call today at 4:30 p.m. ET / 1:30 p.m. PT. For more: bit.ly/4vv3qwC #Ophthalmology #ReplaceandRestore

medicalxpress.com/news/2026-07-h… In the longer term, this could also boost interest in Lineage. $LCTX #oneday…

$LCTX We have already witnessed the miracle. Now we need the courage to remain disciples.

@Stock_Screener2 $LCTX = Golden Ticket

Hot stocks: $IVVD, $LCTX, or $RM? I've created a WhatsApp group, and all stock investors are welcome to join. Get daily real-time updates on stock news and trends. Contact our team via WhatsApp: 🔗wa.me/16464065692

$LCTX A Speculative #Play... If #OpRegen boosts Lineage commercial credibility, it might—paradoxically—become easier to monetize legacy assets. A buyer might think: “If Roche has confidence, perhaps we should take Another Look at those other programs » like VAC2...maybe $SANA :-)

$LCTX @CEO_Culley will participate in a fireside chat hosted by Mayank Mamtani of B. Riley Securities as part of the 2026 Mind, Muscle & Vision Healthcare Summit on July 16 in Boston. For more: bit.ly/3R45Xzo #CellTherapy #Biotech #RegenerativeMedicine #ReplaceandRestore

@li2050il LCTX is on the verge of breaking out of a months-long downtrend. If the price closes convincingly above approximately $1.36 (preferably on high volume), there could be room for a rise towards $1.45–1.65 and eventually even $1.75–2.10.

$LCTX

@TheLaikYobaz Yes

Paraguay milli takımı Fransa maçı sonrası dünyanın en sevilmeyen takımı haline geldi. Sizce bu eleştiriyi hak ettiler mi?

$LCTX Lineage has grown into one of my 25 hobbies... #Rabbithole … but the more I delve into it » despite my extremely limited knowledge - the more I get the impression (even with the most pessimistic outlook) that they are sitting on a goldmine. 🚙Joachim Fruebis

Here is my dear friend @JessieChimni fascinating 🧵 in which he summarises the key highlights from his conversation with @CEO_Culley - @LineageCell’s CEO & IMO one of the BEST BioTech CEOs today. If you’re interested in BioTech do give him a Follow-you won’t regret it! $XBI $LCTX

$LCTX Opregen is just Proof of Platform.

@JessieChimni @CEO_Culley Look forward to the good news.

@MadonnaStock @CEO_Culley x.com/JessieChimni/s…

I had a very good meeting with @CEO_Culley, CEO of $LCTX. We met up for coffee and I am really glad our schedules aligned. Brian was gracious to spend quality and discuss the $LCTX business. I will share my notes over the next few days.

@JessieChimni Thanks … Look forward to the good news!

Jill Howe, CFO of $LCTX, joined CFO Weekly to discuss how biotech finance teams can build systems that create bandwidth for the organization. In the episode, Jill shares her perspective on streamlining procurement and clinical operations, building lean AP workflows, and approaching AI as a practical tool for the finance function. Apple Podcasts: apple.co/4aorBoK YouTube: bit.ly/4vxaUQw @Personiv | #CFOLeadership #FinanceFunction

Go for it Lineage! $LCTX

@wartranslated If he had gone to speak to the European Parliament, the G7, the Council of Europe, or another international body with all his arguments (some of which are understandable in a geopolitical context), a more or less reasonable solution would certainly have been found for all parties

@wartranslated The only man who can stop this useless war is Putin.

Putin stated that Russia is ready for peace negotiations with Ukraine.

@LineageCell @RetinalPhys @eyeballsurgeon When you weigh structural regeneration against 'one-and-done' delivery model, coupled with verified functional gains and the formidable distribution engine of Roche, OpRegen isn't just in the pipelin it's the undisputed market leader in the paradigm shift for geographic atrophy.

Thank you to @RetinalPhys and authors @eyeballsurgeon and Ben Uzorka for including OpRegen® in their review of the therapeutic pipeline for geographic atrophy (GA). Read the full article: bit.ly/3QYhIra #GeographicAtrophy #DryAMD #CellTherapy

BROADWOOD! $STAA is catching a bid. Don’t forget $LCTX. Fundamentals haven’t changed; sentiment has.